Last updated: March 26, 2024
Sponsor: Methodist Health System
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hemorrhage
Treatment
Pelvic Angioembolization
Clinical Study ID
NCT06336889
092.TRA.2018.D
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- • All blunt trauma patients undergoing angiography for pelvic fracture associatedhemorrhage
Exclusion
Exclusion Criteria:
- • Pregnant patients
- Patients < 18 years old
- Patients undergoing angiography greater than 24 hours from arrival
Study Design
Total Participants: 400
Treatment Group(s): 1
Primary Treatment: Pelvic Angioembolization
Phase:
Study Start date:
October 26, 2017
Estimated Completion Date:
October 31, 2024
Study Description
Connect with a study center
Methodist Dallas Medical Center
Dallas, Texas 75201
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.